410 related articles for article (PubMed ID: 25892549)
41. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
42. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
43. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
44. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
47. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.
Lyu X; Fang W; Cai L; Zheng H; Ye Y; Zhang L; Li J; Peng H; Cho WC; Wang E; Marincola FM; Yao K; Cai H; Li J; Li X
Mol Cancer; 2014 Mar; 13():51. PubMed ID: 24606633
[TBL] [Abstract][Full Text] [Related]
48. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
49. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
51. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.
Qi X; Li J; Zhou C; Lv C; Tian M
FEBS Lett; 2014 Oct; 588(20):3732-8. PubMed ID: 25171860
[TBL] [Abstract][Full Text] [Related]
53. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
55. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
Ke Z; Xie F; Zheng C; Chen D
J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
[TBL] [Abstract][Full Text] [Related]
56. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/β-catenin signaling.
Hua X; Fan KC
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1077-1086. PubMed ID: 30779075
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.
Jiang C; Wang H; Zhou L; Jiang T; Xu Y; Xia L
Oncol Rep; 2017 Jul; 38(1):82-88. PubMed ID: 28504814
[TBL] [Abstract][Full Text] [Related]
58. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.
Li Y; Yan L; Zhang W; Wang H; Chen W; Hu N; Ou H
Int J Clin Exp Pathol; 2014; 7(6):3478-87. PubMed ID: 25031780
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of miR-204 facilitates the progression of nasopharyngeal carcinoma by targeting CXCR4 through NF-κB signaling pathway.
Zong G; Han J; Yue Z; Liu Y; Cui Z; Shi L
J BUON; 2020; 25(2):1098-1104. PubMed ID: 32521912
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma.
Chen W; Du M; Hu X; Ma H; Zhang E; Wang T; Yin L; He X; Hu Z
Cancer Med; 2020 Feb; 9(3):1209-1219. PubMed ID: 31859457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]